Skip to the page

Data / Form D filings / Spearhead Bio, Inc.

Spearhead Bio, Inc.: Form D filings

Spearhead Bio, Inc., a technology company in Saint Louis, MO, filed 2 Form D notices with the SEC between 2025 and 2026. The latest, on June 23, 2026, reports $1.2 million sold of a $1.8 million offering to 4 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
975 N WARSON ROAD, Saint Louis, MO, 63132
Phone
(314) 622-6674
Industry
Other Technology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2024
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2057359

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jun 23, 2026New notice$1,750,000$1,200,000$550,0004Jun 18, 2026sec.gov
Feb 21, 2025New notice$1,300,000$1,025,000$275,0005Feb 6, 2025sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Michael BielskiExecutive Officer, Director
Keith SlotkinExecutive Officer, Director
Harold DaviesExecutive Officer, Director
Thomas LauritaDirector

Other technology companies in Missouri that filed recently

Every Form D from the week of Jun 22, 2026 · All recent filings in Missouri · All recent Other Technology filings

Read from SEC EDGAR. Amount sold is what Spearhead Bio, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.